Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Study of Sargramostim in Moderately to Severely Active Crohn's Disease
This study has been terminated.
Study NCT00329537. Last updated on May 5, 2009.
Information provided by Bayer
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Crohn Disease
Additional conditions recognized in this trial
Enteritis
Ileitis
More general conditions related to this trial
Digestive System Diseases
Gastroenteritis
Gastrointestinal Diseases
Ileal Diseases
Inflammatory Bowel Diseases
Intestinal Diseases
Interventions listed in this trial
Leukine (Sargramostim, BAY86-5326)
Placebo
Sponsors listed in this trial
Bayer
Back to top of Main Content